We would like to inform you that Dom Maklerski Banku Ochrony Środowiska S.A. has joined the group of consortium members accepting subscriptions ...Read full
On 02/03/2021 there was an investor chat with our participation. We invite you to watch the chat here: ...Read full
At Bioceltix, we develop innovative MSC-based biopharmaceuticals for use in companion animals. We target markets with high demand for effective pharmaceuticals.
Puls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO round. So far, the company has obtained a total of approx. PLN 20 million in financing for the development of a still innovative method of treating pets using drugs with stem cells.